Mull v. Saul

CourtDistrict Court, E.D. Virginia
DecidedMarch 26, 2021
Docket3:19-cv-00912
StatusUnknown

This text of Mull v. Saul (Mull v. Saul) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mull v. Saul, (E.D. Va. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA Richmond Division

SANDRA M. M., 1 Plaintiff,

v. Civil No. 3:19cv912

ANDREW M. SAUL, Commissioner of Social Security, Defendant.

MEMORANDUM OPINION This is an action seeking review of the decision of the Commissioner of Social Security (“Commissioner”) denying Plaintiff’s application for disability insurance benefits under the Social Security Act. Sandra M. M. (“Plaintiff”), thirty-eight years old at the time of her benefits application, last worked as an office manager at a mobile home company, and as an assistant director at a Department of Corrections facility. (R. at 75.) Plaintiff suffers from diabetes mellitus with neuropathy and gastroparesis, as well as asthma. (R. at 18.) Plaintiff asserts that these impairments significantly impact her ability to perform work-related activities because she experiences nausea, vomiting, and pain that interfere with her ability to work. (R. at 55-60.) On October 24, 2016, Plaintiff filed for disability insurance benefits. (R. at 196.) After Plaintiff’s application was denied, and after exhausting her administrative remedies, Plaintiff seeks review of the Administrative Law Judge’s (“ALJ”) decision. This matter now comes before the

1 The Committee on Court Administration and Case Management of the Judicial Conference of the United States has recommended that, due to significant privacy concerns in social security cases, federal courts should refer to claimants only by their first names and last initials. Court by consent of the parties pursuant to 28 U.S.C. § 636(c)(1), on the parties’ cross motions for summary judgment, rendering the matter ripe for review.2 For the reasons set forth below, the Court DENIES Plaintiff’s Motion for Summary Judgment (ECF No. 15), DENIES Plaintiff’s Motion for Remand (ECF No. 16), GRANTS

Defendant’s Motion for Summary Judgment (ECF No. 21), and AFFIRMS the final decision of the Commissioner. I. PROCEDURAL HISTORY On October 24, 2016, Plaintiff filed an application for disability insurance benefits, alleging disability based on diabetes, neuropathy, asthma, hyperthyroidism, amyloidosis, and gastroesophageal reflux disease (“GERD”). (R. at 188-89.) The Social Security Administration denied Plaintiff’s claim initially on January 4, 2017, and again upon reconsideration on February 21, 2017. (R. at 196, 207.) Plaintiff requested a hearing before an ALJ, and the hearing was held on September 19, 2018. (R. at 44, 221.) On December 27, 2018, the ALJ issued a written opinion, denying Plaintiff’s claim and concluding that Plaintiff did not qualify as disabled. (R. at 15-29.)

Plaintiff requested review of the ALJ’s decision, and on October 30, 2019, the Social Security Administration Appeals Council denied the request, rendering the ALJ’s decision as the final decision of the Commissioner. (R. at 1-3.) Plaintiff now seeks judicial review pursuant to 42 U.S.C. § 405(g).

2 The administrative record in this case remains filed under seal, pursuant to E.D. Va. Loc. R. 5 and 7(C). In accordance with these rules, the Court will exclude personal identifiers such as Plaintiff’s social security number, the names of any minor children, dates of birth (except for year of birth), and financial account numbers from this Memorandum Opinion, and will further restrict its discussion of Plaintiff’s medical information only to the extent necessary to properly analyze the case. II. FACTUAL BACKGROUND Plaintiff alleges that her disability is driven by the symptoms and effects of Type I diabetes, as well as asthma. (R. at 55-64.) As a result of her diabetes, Plaintiff suffers from other conditions such as severe hypoglycemic unawareness, which causes low blood sugar and neuropathy, as well as gastroparesis.3 (R. at 55-56, 60.) Plaintiff alleges that she averages two hypoglycemic seizures

per week, which cause her to lose consciousness and experience confusion. (R. at 57-58, 67.) Plaintiff also alleges that she experiences neuropathy (numbness) in her arms, toes, feet, and legs, and that as a result, she feels pain “all day.” (R. at 59.) Finally, as a result of Plaintiff’s gastroparesis, Plaintiff experiences constipation and frequent vomiting. (R. at 60.) Regarding Plaintiff’s asthma, she has lung nodules, a persistent cough, and she uses a nebulizer for about fifteen minutes twice per day. (R. at 63-64.) Plaintiff has a long history of smoking cigarettes. (R. at 834.) Plaintiff’s treatment records are as follows: In September 2016, Plaintiff began feeling gastrointestinal discomfort, and underwent an

upper gastrointestinal endoscopy, which demonstrated a large hiatal hernia and probable GERD, but otherwise a normal stomach. (R. at 687-88.) Plaintiff then had an esophagram, which demonstrated moderate esophageal dysmotility with narrowing at the gastroesophageal junction, and a small to moderate sliding type hiatal hernia. (R. at 678.)

3 Gastroparesis is “a condition that affects the normal spontaneous movement of the muscles (motility) in your stomach.” Gastroparesis, Mayo Clinic, https://www.mayoclinic.org/diseases- conditions/gastroparesis/symptoms-causes/syc-20355787 (last visited March 19, 2021). Gastroparesis causes a person’s stomach motility to slow down or not work at all, and prevents the stomach from emptying properly. Id. Between October 2016 and October 2017, Plaintiff was seen by a variety of providers, largely to sort out a possible diagnosis for Amyloidosis, which was ultimately ruled out,4 but also for her gastrointestinal symptoms. (R. at 584, 825.) Plaintiff reported symptoms such as weight gain, fatigue, constipation, difficulty swallowing, and vomiting. (R. at 557, 585, 735, 834, 882,

904, 1030.) Plaintiff was seen at the Mayo Clinic from January 2017 to April 2017, “for a comprehensive evaluation of her constellation of symptoms” including evaluations with the Gastroenterology Clinic. (R. at 825, 834, 875, 880, 882, 904-06.) Plaintiff also presented to Duke Health for “another evaluation of her amyloid.” (R. at 790.) While there, she reported nausea and vomiting. (R. at 790.) Though an x-ray did show some constipation, a physical examination of Plaintiff’s her abdomen was largely normal and demonstrated normal bowel sounds, soft abdomen, and no abdominal guarding or tenderness. (R. at 793.) Despite her symptoms, Plaintiff’s providers recommended limited treatment, including an increase in Plaintiff’s water intake; use of a stool softener, probiotics and magnesium; and both dietary and lifestyle changes, including quitting smoking and carb counting. (R. at 559, 737, 835.)

In September 2017, Plaintiff presented to Dr. Matthew Brengman for an initial consultation about diabetic gastroparesis. (R. at 1000.) After discussing surgery options with Plaintiff and reviewing her records from the Mayo Clinic, Dr. Brengman suggested a gastric stimulation and pyloroplasty for her symptoms. (R. at 1002.) Plaintiff underwent surgery in October 2017 to place the gastric stimulator. (R. at 992, 1410.) Two weeks after her surgery, Plaintiff reported that her

4 Amyloidosis is “a rare disease that occurs when an abnormal protein, called amyloid, builds up in your organs and interferes with their normal function.” Amyloidosis, Mayo Clinic, https://www.mayoclinic.org/diseases-conditions/amyloidosis/symptoms-causes/syc-20353178 (last visited March 3, 2021). Plaintiff went through an extensive workup at the Mayo Clinic (R.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Mull v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mull-v-saul-vaed-2021.